NY Proton Center initiates three studies on FLASH radiation therapy

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The New York Proton Center has initiated three FLASH radiation therapy mouse model studies that will examine the use of FLASH RT to improve treatment of lung, pelvic, and abdominal tumors. NYPC researchers are conducting the studies in partnership with oncologists at Memorial Sloan Kettering Cancer Center, Montefiore Einstein Cancer Center, and Mount Sinai Health System.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

According to preliminary data from a multi-institution phase III trial led by researchers at MD Anderson Cancer Center, intensity modulated proton therapy achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy as part of chemoradiation treatment for patients with oropharyngeal cancer. 
Nationwide Children’s Hospital and The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute opened a $100 million, 55,000 square foot proton therapy center. It is the first treatment facility in central Ohio offering this highly targeted form of radiation therapy for treatment of complex tumors that cannot be removed through surgery.

Login